SCHEMBL29919210

SCHEMBL29919210

COc1cc(Cl)nnc1NC1C[C@@H]2CN(C(=O)C3CCOCC3)C[C@@H]2C1

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.42
JAK1 P23458 2/20 0.42
PIK3CD O00329 12/20 0.41
PIK3CA P42336 9/20 0.41
LMNA P02545 2/20 0.40
LRRK2 Q5S007 2/20 0.38
PIK3CB P42338 5/20 0.38
PIK3CG P48736 5/20 0.38
ALDH1A1 P00352 1/20 0.36
JAK2 O60674 1/20 0.35
FLT3 P36888 1/20 0.35
AURKB Q96GD4 1/20 0.35
PIK3R1 P27986 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24574674 1.00 AURKA (0.42) AURKAJAK1PIK3CDPIK3CALMNA
SCHEMBL23499425 0.84 JAK1 (0.42) AURKAJAK1PIK3CDPIK3CAPIK3CB
SCHEMBL23499429 0.84 JAK1 (0.42) AURKAJAK1PIK3CDPIK3CAPIK3CB
SCHEMBL23499427 0.84 JAK1 (0.42) AURKAJAK1PIK3CDPIK3CAPIK3CB
SCHEMBL31119103 0.84 ATXN2 (0.45) AURKAJAK1PIK3CDPIK3CAJAK2
SCHEMBL24575288 0.84 ATXN2 (0.45) AURKAJAK1PIK3CDPIK3CAJAK2
SCHEMBL23499494 0.83 JAK1 (0.38) AURKAJAK1LMNAALDH1A1JAK2
SCHEMBL23499495 0.83 JAK1 (0.38) AURKAJAK1LMNAALDH1A1JAK2
SCHEMBL23499496 0.83 JAK1 (0.38) AURKAJAK1LMNAALDH1A1JAK2
SCHEMBL23933533 0.82 JAK1 (0.41) AURKAJAK1PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118541365-A Antagonists of muscarinic acetylcholine receptor M4 范德堡大学 2024-08-23 CN disclosed
WO-2022216655-A1 N-(6-((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YI)AMINO)PYRIDAZIN-3-YL)PHENYL)CARBOXAMIDE AND (6- ((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YL)AMINO)PYRIDAZIN-3-YL)BENZAMIDE DERIVATIVES AS MACHR M4 ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS VANDERBILT UNIVERSITY (US) 2022-10-13 WO disclosed
WO-2022212819-A1 INDAZOLE DERIVATIVES AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY (US) 2022-10-06 WO disclosed